Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Ltd ( (AU:OCC) ) has shared an update.
Orthocell Ltd has notified the market that 16,567 retention rights, classified as OCCAAH securities, have lapsed after conditions attached to these rights were not met or became incapable of being satisfied. The cessation of these conditional securities, effective 31 December 2025, results in a small reduction of potential future equity issuance and slightly streamlines the company’s capital structure without impacting existing ordinary shareholders.
The announcement, lodged as a new Appendix 3H on 16 March 2026, reflects Orthocell’s ongoing obligations to keep investors informed of changes to its issued and potential capital. While the lapse of retention rights may signal that certain performance or service milestones were not achieved, it also limits dilution for current investors and underscores the contingent nature of incentive-based equity awards in ASX-listed companies.
The most recent analyst rating on (AU:OCC) stock is a Sell with a A$0.77 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd, listed on the ASX under the code OCC, is an Australian company whose announcement relates to its issued capital structure. The business operates within the corporate and securities framework of the ASX, managing various classes of securities including retention rights granted to participants under its equity arrangements.
Average Trading Volume: 435,747
Technical Sentiment Signal: Hold
Current Market Cap: A$219.8M
Learn more about OCC stock on TipRanks’ Stock Analysis page.